Displaying 1–10 of 14 news results
Oct 6, 2020 Foundation News
May 7, 2020 Foundation News
Delays in Research Impacting Therapy Development
Mar 31, 2020 Foundation News
The Foundation Fighting Blindness is closely monitoring the COVID-19 situation and its impact on the IRD community.
Feb 3, 2020 Foundation News
Please note that the seventh annual Retinal Cell and Gene Therapy Innovation Summit previously scheduled for Friday, May 1st, 2020 in Baltimore, Maryland has been cancelled.
Jan 29, 2020 Foundation News
The Foundation Fighting Blindness VISIONS 2020 conference will be held on June 18-20th at the Hyatt Regency Minneapolis.
Aug 16, 2019 Foundation News
The newly funded research efforts include several therapies that have strong potential to treat a wide range of inherited retinal diseases.
Jun 3, 2019 Foundation News
A discussion of strategies concerning the development of autosomal dominant disease therapies at the Translational Research Acceleration Program (TRAP) in November 2013.
Mar 7, 2019 Foundation News
Age-related macular degeneration (AMD) is the leading cause of blindness for people over 50 years of age in developed countries.
Oct 18, 2018 Foundation News
More than two decades ago, the Foundation Fighting Blindness (FFB) began funding RPE65 gene therapy research that led in late 2017 to LUXTURNA™, the first FDA-approved gene therapy for the eye or an inherited condition. Ultimately, the Foundation provided more than $10 million in funding for the groundbreaking effort.
Apr 13, 2016 Foundation News
David Brint has been elected Chairman, effective July 1, 2016. Brint succeeds co-founder and current Chairman, Gordon Gund, who will remain a member of the Board of Directors and will continue to be actively involved in the Foundation’s Research Oversight Committee